The drug had a 0.3mL favourable difference on ... the eGFR chronic slope compared with the control, Sanofi’s Aprovel (irbesartan). However, it wasn’t statistically significant.

“Kudos to them that they knew what to look for.” Podcast: New lasso-shaped antibiotic kills drug-resistant bacteria The latest molecule targets bacteria’s protein-making factory, the ...

The drug – already granted accelerated approval ... a maximally labelled dose of angiotensin 2 receptor antagonist irbesartan, a current standard of care. The company launched Filspari at ...